Exact Sciences
Healthcare Services · Wisconsin, United States · 6,500 Employees
View Company Info for Free
About
Headquarters
5505 Endeavor Ln, Madison, Wisconsin, 53719, Un...Phone Number
(608) 284-5700Website
www.exactsciences.comRevenue
$2.6 BillionStock Symbol
EXASIndustry
Most Recent Scoops
Highlights
$56M
Total Funding Amount
$56M
Most Recent Funding Amount
1
Number of Funding Rounds
Who is Exact Sciences
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Colo guard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.Read more
Popular SearchesEXACT Sciences CorpExact SciencesExact Sciences Laboratories LLCExact ScienceExact Science IncSIC Code 80,807NAICS Code 62,621Ticker NASDAQ: EXASShow moreExact Sciences Org Chart
Is Exact Sciences your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Exact Sciences launches new products
Click to see if Exact Sciences had a recent Job posting/layoffs
Earning: See what the market has to say on Exact Sciences recently announced quarterly report
Check out if Exact Sciences is spiking on competitors!
Check if Exact Sciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Exact Sciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Exact Sciences
Website visits: Recent activity has been detected on your website
Exact Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Exact Sciences as Masked Content
Find 3 more new buyers
Similar Companies to Exact Sciences
Analyze insights from companies similar to Exact Sciences and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Myriad Genetics2,700$802.2M
- Hologic6,990$4B
- Cepheid4,052$1B
- NeoGenomics2,100$628.2M
- OPKO Health3,930$716.4M
- IDEXX11,000$3.8B
- Randox3,300$619.5M
- Natera3,282$1.4B
More similar companies
Exact Sciences Email Formats
Exact Sciences uses at least 5 email formats with first initials + last (ex. JSmith@exactsciences.com) being used 74.8% of the time
Exact Sciences Email Formats | Percentage | |
---|---|---|
first initials + last | JSmith@exactsciences.com | 74.8% |
first initials + last | JSmith@genomichealth.com | 11.1% |
first initials + middle initials + last | JLSmith@exactsciences.com | 7% |
first.last | John.Smith@exactsciences.com | |
first + last | JohnSmith@exactsciences.com |
Get Verified Emails
Exact Sciences financials insights
Gather financial insights about Exact Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Exact Sciences Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Exact Sciences Tech Stack
A closer look at the technologies used by Exact Sciences
Most Recent Scoops
Exact Sciences News & Media
Exact Sciences Corporation (EXAS) at Wells Fargo 2024 Healthcare Conference - Transcript
Exact Sciences Corporation (NASDAQ:EXAS) Wells Fargo 2024 Healthcare Conference September 5, 2024 3:45 PM ETCompany ParticipantsAaron Bloomer - Chief...Exact Sciences to Participate in September Investor Conferences
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. Wells Fargo Healthcare Conference, Boston Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET Baird Global Healthcare Conference, New York Fireside chat on Wednesday, September 11, 2024 at 10:15 a.m. ET The webcasts can be aExact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the first patient has joined its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence (RWE) study at Baylor Scott & White, the primary study site and largest not-for-profit health system in Texas. The multi-site study will enroll up to 25,000 patients, evaluating the clinical performance, patient and provider experience, anNew Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, shared new modeling data today describing the projected impact of the Cologuard test on patients, health care professionals, and the U.S. health care system since its FDA approval 10 years ago. The data assessed the far-reaching benefits of the first and only multi-target stool DNA test for patients, their families, and the health care system. Over the past 10
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Exact Sciences
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; O... Read More